Curriculum Vitae
Scientific Career
| 1989 -1996 | Diploma study (Austrian diploma) of Biotechnology at the University of Agricultural Sciences (BOKU) in Vienna, Austria |
| 1995 -1996 | Diploma at the Vienna Biocenter: 'Structures of DNA-polylysine complexes and their influence on gene transfer' |
| 1996 - 1999 | Ph.D. work at the Vienna Biocenter: 'Structure and biological properties of DNA-polycation complexes' |
| 1999 - 2000 | Postdoctoral research fellow, CRC Institute for Cancer Research in Birmingham/UK |
| 2000 - 2001 | Marie Curie Fellow, CRC Institute for Cancer Research in Birmingham/UK |
| 2001 - 2013 | Groupleader Vectorology, Department of Pharmacy, Centre of Drug Research, LMU Munich, Germany |
| 2001-2007 | Akademischer Rat (since 2004 tenure) |
| 2007-2013 | Akademischer Oberrat (tenure) |
| 2009 | Habilitation in Pharmaceutical Biology and Pharmaceutical Biotechnology |
| Since 2013 | Professor for Pharmaceutical Sciences, Centre of Pharmaceutical Sciences, University of Vienna |
Memberships
Deutsche Gesellschaft für Gentherapie (DGGT)
European Society for Gene and Cell Therapy (ESGCT)
American Society for Gene and Cell Therapy (ASGCT)
Editorial Activities
| Since 2006 | Editorial board of Recent Patents on Drug Delivery & Formulation |
| Since 2009 | Associate editor of Therapeutic Delivery |
| Since 2012 | Editorial board member of Journal of Pharmaceutics |
| 2014 - 2016 | Editorial board member of European Journal of Pharmaceutics and Biopharmaceutics |
| Since 2015 | Associate editor in chief 'Journal of Drug Design, Development and Therapy’ |
| Since 2016 | Editor of 'European Journal of Pharmaceutics and Biopharmaceutics’ |
Grants / Funds
| 2000-2001 | Marie Curie Individual Fellowship (Category 30) Proposal No. MCFI-2000-00509 'Development of triggered endosomolysis mechanism for improved gene therapy' CRC Institute for Cancer Studies, Birmingham, UK duration: 24 months |
| 2004-2006 | Wilhelm-Sander Stiftung (Germany), 'Hochwirksame lokale Chemotherapie nach tumorgerichtetem Gentransfer in vivo' |
| 2004-2007 | Impuls- und Vernetzungsfonds der Helmholtz-Gemeinschaft Deutscher Forschungszentren, 'Clinical Hyperthermia and Related Technology' |
| 2005-2006 | Deutscher Akademischer Austauschdienst (DAAD), 'Non-viral Phosphorus-containing Gene-Transfer Vectors for Systemic Tumor Targeting' |
| Since 2006 | DFG research network SPP1230 (Gene therapy – vector safety) |
| 2007 | DFG: Forschungsaufenthalt Prof Kolio Troev (Institute of Polymers, Bulgarian Academy of Sciences) DFG |
| 2008-2011 | DFG Sachbeihilfe: Optimierung und therapeutische Anwendung tumorselektiver siRNA Formulierungen gegen Komponenten des Wnt-Signalwegs in gastrointerstinalen Tumormodellen |
| since 2009 | DFG Collaborative research center SFB 824 "Imaging for the Selection, Monitoring and Individualisation of Cancer Therapy": Project ‘Tumor specific molecularly targeted therapy using the sodium iodide symporter as reporter and therapy gene’ (together with Prof Christine Spitzweg, Klinikum Großhadern) |
| 2011 | Center for NanoScience research collaboration grant ‘Polymer coated Adenovirus for cancer gene therapy – correlating ultrastructure with biological activity’ (together with Prof Christina Scheu, Department of Chemistry, LMU) |
| 2011-2012 | Bayerische Forschungsstiftung: PostDoc research fellowship for Dr Joana Viola (PDOC 78-11): ’ Development of a tailored non-viral gene delivery system directed to advanced melanoma.’ |
| 2012 | BMBF grant 01EU1202 |
| 2012 | Center for NanoScience research collaboration grant ‘Covalent vs non-covalent dendrimer coating of Adenovirus: Implications on ultrastructure and transgene expression’ (together with Prof Christina Scheu, Department of Chemistry, LMU) |
| 2012-2017 | Innovative Medicines Initiative (IMI) collaborative research project COMPACT (Collaboration on the Optimisation of Macromolecular Pharmaceutical Access to Cellular Targets) |
| 2017-2021 | Hochschulraum-Strukturmittel Fond des Bundesministeriums für Bildung, Wissenschaft und Forschung (BMBWF): NANOBILD (Cluster für Nanomaterialien-basierende multimodale medizinische Bildgebung) |
| 2018-2019 | 3Dpatho: Einfaches und schnelles Lichtscheiben-Fluoreszenzmikro-skopsystem zur tomographischen Erfassung von biologischen Proben für den klinischen Alltag in der Pathologie |
| 2020-2023 | FFG BRIDGE project BGs for PDAC: Bacterial ghosts as immune-stimulating adjuvant to chemotherapy in pancreatic ductal adenocarcinoma |